AP NEWS

Cancer Screening Market in the U.K. (2018-2023) - ResearchAndMarkets.com

November 19, 2018

DUBLIN--(BUSINESS WIRE)--Nov 19, 2018--The “Cancer Screening Market in the U.K (2018-2023)” report has been added to ResearchAndMarkets.com’s offering.

The United Kingdom (U.K.) stands next to the United States of America (U.S.A.) in coming up with latest technologies to combat the spread of cancer. The cancer screening market in the U.K. is expected to reach USD Bn by 2023 at a CAGR of 8.5%.

Cancer screening market in the U.K. is classified by end users, screening type, and applications. By end users, it is further classified into hospitals, laboratories and independent physicians and clinics. By screening type, it is classified into laboratory, genetic, biopsy, imaging and endoscopy testing. By application type, it is further classified into lung, breast, melanoma, kidney and colorectal type.

Increasing prevalence of cancer, funded initiatives from the government side and the growing trend to follow a sedentary lifestyle are the Key growth factors in this region.

The complicated regulatory framework has the potential to halt the growth of the market. The exorbitant cost of the services and medicinal methodologies can cease he growth of the market.

The key players operating in the valve market are Abbott Healthcare, Agilent, Becton Dickinson, Biomedical Diagnostics, Qiagen, Thermo Fisher Scientific and Bio-Rad.

Key Topics Covered

Chapter 1: Executive summary

1.1 Market scope and segmentation

1.2 Key questions answered in this study

1.3 Executive summary

Chapter 2: Cancer screening market in the U.K. - market overview

2.1. The U.K. market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD)

2.2. The U.K. - market drivers and challenges

2.3. Value chain analysis - cancer screening market in the U.K.

2.4. Porter’s five forces analysis

Chapter 3. Cancer screening market in the U.K. - by end users

3.1. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

3.2. Laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

3.3. Independent physicians and clinics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 4. Cancer screening market in the U.K. - by screening type

4.1. Laboratory testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

4.2. Genetic testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

4.3. Imaging testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

4.4. Biopsy testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

4.5. Endoscopy testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 5. Cancer screening market in the U.K. - by application

5.1. Lung cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

5.2. Breast cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

5.3. Melanoma cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

5.4. Kidney cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

5.5. Colorectal cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 6: Competitive landscape

6.1. Abbott Laboratories (*)

6.1. a. Company snapshot

6.1. b. Product offerings

6.1. c. Growth strategies

6.1. d. Initiatives

6.1. e. Geographical presence

6.1. f. Key numbers

6.2. Agilent Technologies

6.3. Becton Dickinson

6.4. Biomedical Diagnostics

6.5. Qiagen

6.6. Thermo Fisher Scientific

6.7. Bio-Rad

(*) all the information are similar for the mentioned companies

Chapter 7: Conclusion

For more information about this report visit https://www.researchandmarkets.com/research/zvrdgq/cancer_screening?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181119005848/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics

KEYWORD: UNITED KINGDOM EUROPE

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/19/2018 04:19 PM/DISC: 11/19/2018 04:19 PM

http://www.businesswire.com/news/home/20181119005848/en

AP RADIO
Update hourly